Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: MYOCARDIAL INFARCTION - DRUG THERAPY , . Treffer: 23

2022

von, Lewinski, D; Kolesnik, E; Tripolt, NJ; Pferschy, PN; Benedikt, M; Wallner, M; Alber, H; Berger, R; Lichtenauer, M; Saely, CH; Moertl, D; Auersperg, P; Reiter, C; Rieder, T; Siller-Matula, JM; Gager, GM; Hasun, M; Weidinger, F; Pieber, TR; Zechner, PM; Herrmann, M; Zirlik, A; Holman, RR; Oulhaj, A; Sourij, H Empagliflozin in acute myocardial infarction: the EMMY trial.
Eur Heart J. 2022; 43(41):4421-4432 Doi: 10.1093/eurheartj/ehac494 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2021

von, Lewinski, D; Benedikt, M; Tripolt, N; Wallner, M; Sourij, H; Kolesnik, E Can sodium-glucose cotransporter 2 inhibitors be beneficial in patients with acute myocardial infarction?
Kardiol Pol. 2021; 79(5):503-509 Doi: 10.33963/KP.15969 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Weiss, TW; Aichinger, J; Huber, K; Speidl, WS; Watzinger, N; Zweiker, R; Alber, HF Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction.
Wien Klin Wochenschr. 2016; 128(11-12):450-457 Doi: 10.1007/s00508-016-1016-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Slavic, S; Lauer, D; Sommerfeld, M; Kemnitz, UR; Grzesiak, A; Trappiel, M; Thöne-Reineke, C; Baulmann, J; Paulis, L; Kappert, K; Kintscher, U; Unger, T; Kaschina, E Cannabinoid receptor 1 inhibition improves cardiac function and remodelling after myocardial infarction and in experimental metabolic syndrome.
J Mol Med (Berl). 2013; 91(7):811-823 Doi: 10.1007/s00109-013-1034-0
Web of Science PubMed FullText FullText_MUG

 

2012

Morrow, DA; Braunwald, E; Bonaca, MP; Ameriso, SF; Dalby, AJ; Fish, MP; Fox, KA; Lipka, LJ; Liu, X; Nicolau, JC; Ophuis, AJ; Paolasso, E; Scirica, BM; Spinar, J; Theroux, P; Wiviott, SD; Strony, J; Murphy, SA; TRA 2P–TIMI 50 Steering Committee and Investigators Vorapaxar in the secondary prevention of atherothrombotic events.
N Engl J Med. 2012; 366(15):1404-1413 Doi: 10.1056/NEJMoa1200933 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

De Vuyst, E; Boengler, K; Antoons, G; Sipido, KR; Schulz, R; Leybaert, L Pharmacological modulation of connexin-formed channels in cardiac pathophysiology.
Br J Pharmacol. 2011; 163(3):469-483 Doi: 10.1111/j.1476-5381.2011.01244.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2006

Hartig, F; Eller, P; Pechlaner, C Fondaparinux in patients with ST-segment elevation myocardial infarction.
JAMA. 2006; 296(17): 2087; author reply 2088-2087; author reply 2089. Doi: 10.1001/jama.296.17.2087-a
Web of Science PubMed FullText FullText_MUG

 

Toller, WG; Stranz, C Levosimendan, a new inotropic and vasodilator agent.
ANESTHESIOLOGY. 2006; 104(3): 556-569. Doi: 10.1097/00000542-200603000-00024 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2005

Granger, CB; Steg, PG; Peterson, E; López-Sendón, J; Van de Werf, F; Kline-Rogers, E; Allegrone, J; Dabbous, OH; Klein, W; Fox, KA; Eagle, KA; GRACE Investigators Medication performance measures and mortality following acute coronary syndromes.
Am J Med. 2005; 118(8):858-865 Doi: 10.1016/j.amjmed.2005.01.070
Web of Science PubMed FullText FullText_MUG

 

2004

Zirlik, A TAFI: a promising drug target?
THROMB HAEMOSTASIS. 2004; 91(3): 420-422. Doi: 10.1055/s-0037-1614285
Web of Science PubMed FullText FullText_MUG

 

2003

Hödl, R; Klein, W The role of low-molecular-weight heparins in cardiovascular medicine.
J Clin Pharm Ther. 2003; 28(5):371-378 Doi: 10.1046%2Fj.0269-4727.2003.00504.x
Web of Science PubMed FullText FullText_MUG

 

2002

Newby, LK; Kristinsson, A; Bhapkar, MV; Aylward, PE; Dimas, AP; Klein, WW; McGuire, DK; Moliterno, DJ; Verheugt, FW; Weaver, WD; Califf, RM; SYMPHONY and 2nd SYMPHONY Investigators. Sibrafiban vs Aspirin to Yield Maximun Protection From Ischemic Heart Events Post-acute Coronary Syndromes Early statin initiation and outcomes in patients with acute coronary syndromes.
JAMA-J AM MED ASSN. 2002; 287(23): 3087-3095. Doi: 10.1001/jama.287.23.3087 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2001

Hödl, R; Kraxner, W; Maier, R; Klein, W Dosing regimen of reteplase and costeffectiveness.
Lancet. 2001; 358(9291):1462-1462 Doi: 10.1016/S0140-6736(01)06513-8
Web of Science PubMed FullText FullText_MUG

 

Klein, WW Secondary prevention: is inpatient rehabilitation effective or are lifestyle changes to be replaced by drugs?
Eur Heart J. 2001; 22(13):1063-1064 Doi: 10.1053/euhj.2000.2595 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2000

Szucs, TD; Berger, K; März, W; Schäfer, JR Cost effectiveness of pravastatin in secondary coronary prevention in patients with myocardial infarct or unstable angina in Germany. An analysis on the basis of the LIPID trial
Herz. 2000; 25(5): 487-494. Doi: 10.1007/PL00001961
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Weidenbach, R; Schulz, R; Gres, P; Behrends, M; Post, H; Heusch, G Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism.
Br J Pharmacol. 2000; 131(1):138-144 Doi: 10.1038/sj.bjp.0703544 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1999

Toller, WG; Kersten, JR; Pagel, PS; Hettrick, DA; Warltier, DC Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs.
Anesthesiology. 1999; 91(5):1437-1446 Doi: 10.1097/00000542-199911000-00037 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

1997

Toplak, H; Bahadori, B; Wascher, TC CAPRIE trial.
Lancet. 1997; 349(9048):354; author reply 356-354; author reply 356 Doi: 10.1016/S0140-6736(05)62849-8
Web of Science PubMed FullText FullText_MUG

 

1996

Klein, W; Eber, B; Gasser, R; Stoschitzky, K; Schumacher, M; Fruhwald, FM; Zweiker, R Current aspects of ACE inhibitor therapy from the cardiologic viewpoint
Wien Med Wochenschr. 1996; 146(11):221-224
PubMed

 

1995

Fruhwald, FM; Luha, O; Eber, B; Schumacher, M; Zweiker, R; Klein, W Systemic thrombolysis for early intracoronary stent thrombosis.
LANCET . 1995; 346(8967): 119-120. Doi: 10.1016/S0140-6736(95)92142-7 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

1994

Holubarsch, C; Pieske, B; Hasenfuss, G; Just, H Use of enoximone in patients with acute and subacute heart failure in the intensive care unit
Z Kardiol. 1994; 83 Suppl 2(2): 21-25.
Web of Science PubMed Google Scholar

 

1992

Klein, W Streptokinase full circle.
Lancet. 1992; 339(8789):363-363 Doi: 10.1016/0140-6736(92)91680-7
Web of Science PubMed FullText FullText_MUG

 

1986

Simmet, T; Peskar, BA Eicosanoids and the coronary circulation.
Rev Physiol Biochem Pharmacol. 1986; 104(2):1-64 Doi: 10.1007/BFb0031012
Web of Science PubMed FullText FullText_MUG Google Scholar

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum